Hjem › Type 2-diabetes › Washington
Type 2-diabetes kliniske forsøg i Washington
20 studier for Type 2-diabetes søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- ERA Health Research - Redmond, Redmond
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Providence Regional Medical Center Everett, Everett
- University of Washington, Seattle
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
- Sleep and Performance Research Center, Spokane
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 til 45 · Alle køn · Opdateret 18. sep. 2026 · NCT07494084A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Seattle
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Era Health Research, Redmond
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Eastside Research Associates, Redmond
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- The Vancouver Clinic, Vancouver
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Renton
- Research Site, Seattle
- Research Site, Seattle
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Seattle Children's Research Institute, Seattle
RekruttererFase 3
Alder 10 til 18 · Alle køn · Opdateret 9. sep. 2026 · NCT07282613A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Northwest Clinical Research Center, Bellevue
- Rainier Clinical Research Center, Renton
- Universal Research Group, Tacoma
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT07215559A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Redmond
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Renton
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Renton
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 25. aug. 2026 · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Seattle Children's Hospital, Seattle
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Renton
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT07664553ROME GS System Study
- Rainier Clinical Research Center, Renton
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 21. apr. 2026 · NCT07518004Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
- Seattle Children's Hospital, Seattle
- University of Washington Medicine Diabetes Institute, Seattle
Rekrutterer
Alder 14 til 40 · Alle køn · Opdateret 13. jun. 2025 · NCT06936670Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
- Seattle Children's Hospital, Seattle
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 8 til 14 · Alle køn · Opdateret 24. mar. 2025 · NCT05008276Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- University of Washington - Harborview Medical Center, Seattle
RekruttererFase 4
Alder 40 til 65 · Alle køn · Opdateret 5. jun. 2024 · NCT05780905Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.